Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.87
CI's Cash-to-Debt is ranked lower than
64% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. CI: 0.87 )
Ranked among companies with meaningful Cash-to-Debt only.
CI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.28  Med: 0.9 Max: N/A
Current: 0.87
Equity-to-Asset 0.23
CI's Equity-to-Asset is ranked lower than
76% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.34 vs. CI: 0.23 )
Ranked among companies with meaningful Equity-to-Asset only.
CI' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.04  Med: 0.12 Max: 0.23
Current: 0.23
0.04
0.23
Interest Coverage 12.20
CI's Interest Coverage is ranked lower than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.62 vs. CI: 12.20 )
Ranked among companies with meaningful Interest Coverage only.
CI' s Interest Coverage Range Over the Past 10 Years
Min: 8.24  Med: 11.65 Max: N/A
Current: 12.2
Beneish M-Score: -2.86
WACC vs ROIC
4.94%
12.85%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 7.59
CI's Operating Margin % is ranked higher than
72% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.19 vs. CI: 7.59 )
Ranked among companies with meaningful Operating Margin % only.
CI' s Operating Margin % Range Over the Past 10 Years
Min: 1.98  Med: 8.79 Max: 10.31
Current: 7.59
1.98
10.31
Net Margin % 4.84
CI's Net Margin % is ranked higher than
72% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.19 vs. CI: 4.84 )
Ranked among companies with meaningful Net Margin % only.
CI' s Net Margin % Range Over the Past 10 Years
Min: 1.53  Med: 5.8 Max: 7.07
Current: 4.84
1.53
7.07
ROE % 14.32
CI's ROE % is ranked lower than
52% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.42 vs. CI: 14.32 )
Ranked among companies with meaningful ROE % only.
CI' s ROE % Range Over the Past 10 Years
Min: 7  Med: 18.14 Max: 28.9
Current: 14.32
7
28.9
ROA % 3.25
CI's ROA % is ranked lower than
68% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.26 vs. CI: 3.25 )
Ranked among companies with meaningful ROA % only.
CI' s ROA % Range Over the Past 10 Years
Min: 0.72  Med: 3.06 Max: 3.81
Current: 3.25
0.72
3.81
3-Year Revenue Growth Rate 10.20
CI's 3-Year Revenue Growth Rate is ranked lower than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. CI: 10.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CI' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 5.4 Max: 18.2
Current: 10.2
0
18.2
3-Year EBITDA Growth Rate 11.40
CI's 3-Year EBITDA Growth Rate is ranked lower than
58% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.80 vs. CI: 11.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CI' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 7.7 Max: 112.6
Current: 11.4
0
112.6
3-Year EPS without NRI Growth Rate 11.50
CI's 3-Year EPS without NRI Growth Rate is ranked higher than
71% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.40 vs. CI: 11.50 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CI' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -32  Med: 6.6 Max: 79.9
Current: 11.5
-32
79.9
GuruFocus has detected 6 Warning Signs with Cigna Corp $CI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CI's 30-Y Financials

Financials (Next Earnings Date: 2017-11-03 Est.)


Revenue & Net Income
Equity & Asset
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

CI Guru Trades in Q2 2016

John Paulson 61,800 sh (New)
Steven Cohen 143,700 sh (New)
Paul Tudor Jones 3,900 sh (New)
Louis Moore Bacon 1,785 sh (New)
NWQ Managers 672,362 sh (+59.20%)
Jim Simons 401,700 sh (+47.41%)
David Dreman 283 sh (+41.50%)
Lee Ainslie 9,710 sh (+26.10%)
Andreas Halvorsen 501,208 sh (+25.19%)
Dodge & Cox 15,282,616 sh (+12.75%)
Keeley Asset Management Corp 12,880 sh (+11.52%)
Mairs and Power 4,801 sh (+2.26%)
Richard Pzena 771,405 sh (+1.27%)
Larry Robbins 6,106,123 sh (+0.18%)
Vanguard Health Care Fund 7,105,831 sh (unchged)
David Einhorn 435,000 sh (unchged)
Eric Mindich 500,000 sh (unchged)
George Soros Sold Out
John Hussman Sold Out
Jeremy Grantham Sold Out
Eric Mindich Sold Out
Pioneer Investments 18,887 sh (-0.73%)
Barrow, Hanley, Mewhinney & Strauss 2,375,427 sh (-4.26%)
Mario Gabelli 15,000 sh (-5.06%)
Joel Greenblatt 11,919 sh (-78.52%)
» More
Q3 2016

CI Guru Trades in Q3 2016

George Soros 13,000 sh (New)
Lee Ainslie 456,283 sh (+4599.10%)
Joel Greenblatt 18,684 sh (+56.76%)
Steven Cohen 193,000 sh (+34.31%)
Richard Pzena 906,125 sh (+17.46%)
Vanguard Health Care Fund 7,533,631 sh (+6.02%)
Mario Gabelli 15,000 sh (unchged)
David Dreman 283 sh (unchged)
David Einhorn 435,000 sh (unchged)
Eric Mindich 500,000 sh (unchged)
Pioneer Investments 18,887 sh (unchged)
John Paulson Sold Out
Andreas Halvorsen Sold Out
Paul Tudor Jones Sold Out
Jim Simons Sold Out
Louis Moore Bacon Sold Out
Signature Select Canadian Fund Sold Out
Keeley Asset Management Corp 12,730 sh (-1.16%)
Larry Robbins 5,991,396 sh (-1.88%)
Mairs and Power 4,695 sh (-2.21%)
Dodge & Cox 14,448,844 sh (-5.46%)
Barrow, Hanley, Mewhinney & Strauss 2,057,208 sh (-13.40%)
NWQ Managers 460,741 sh (-31.47%)
» More
Q4 2016

CI Guru Trades in Q4 2016

Paul Tudor Jones 3,800 sh (New)
Jim Simons 462,900 sh (New)
Lee Ainslie 2,013,625 sh (+341.31%)
George Soros 36,902 sh (+183.86%)
Richard Pzena 2,317,548 sh (+155.76%)
Joel Greenblatt 27,831 sh (+48.96%)
Steven Cohen 228,700 sh (+18.50%)
Keeley Asset Management Corp 14,120 sh (+10.92%)
Vanguard Health Care Fund 7,804,631 sh (+3.60%)
Dodge & Cox 14,465,358 sh (+0.11%)
Mario Gabelli 15,000 sh (unchged)
David Einhorn 435,000 sh (unchged)
Eric Mindich 500,000 sh (unchged)
Pioneer Investments 18,887 sh (unchged)
Barrow, Hanley, Mewhinney & Strauss 2,012,803 sh (-2.16%)
Mairs and Power 4,500 sh (-4.15%)
Larry Robbins 5,662,086 sh (-5.50%)
NWQ Managers 430,840 sh (-6.49%)
David Dreman 39 sh (-86.22%)
» More
Q1 2017

CI Guru Trades in Q1 2017

Alan Fournier 322,500 sh (New)
Paul Tudor Jones 25,886 sh (+581.21%)
Jim Simons 658,900 sh (+42.34%)
Lee Ainslie 2,456,819 sh (+22.01%)
Joel Greenblatt 33,158 sh (+19.14%)
Vanguard Health Care Fund 7,804,631 sh (unchged)
David Einhorn 435,000 sh (unchged)
Mairs and Power 4,500 sh (unchged)
Pioneer Investments 18,887 sh (unchged)
David Dreman Sold Out
George Soros Sold Out
Steven Cohen Sold Out
Dodge & Cox 14,399,578 sh (-0.45%)
Barrow, Hanley, Mewhinney & Strauss 1,974,863 sh (-1.88%)
Richard Pzena 2,256,353 sh (-2.64%)
NWQ Managers 416,144 sh (-3.41%)
Larry Robbins 4,905,428 sh (-13.36%)
Mario Gabelli 10,650 sh (-29.00%)
» More
» Details

Insider Trades

Latest Guru Trades with CI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NYSE:ANTM, NYSE:AET, NAS:ESRX, NYSE:HUM, NYSE:CNC, NYSE:CVS, NYSE:WCG, NYSE:MOH, NAS:MGLN, NAS:HIIQ, OTCPK:OPRX, OTCPK:WCUI, NAS:CNXR, NYSE:UNH » details
Traded in other countries:CGN.Germany,
Headquarter Location:USA
Cigna Corp operates in the healthcare industry. It provides medical, dental, disability, life and accident insurance products.

Cigna is one of the largest managed-care organizations in the United States, with a little over 14 million medical members. The firm provides health insurance services to individuals mainly through the group (employer) market. Cigna is one of the leaders in the commercial self-funded fee market, which is where most of the growth has and will continue to come from for the large-group segment. The firm also participates in other insurance and retirement businesses that make up a material portion of its total operations.

Top Ranked Articles about Cigna Corp

Cigna and CVS Health Launch Cigna Health Works, A New Model for Customer-Enabled Design for Affordable, Convenient Access to Pharmacy and Health Care
How to Invest in Structured Settlements Returns are good, but the risks are hidden
Structured settlements are usually associated with compensation to injured plaintiffs following a legal hearing. They are more than just a mere compensation package, however. One of their main characteristics is they are meant to cover any medical expenses the injured plaintiff may incur in relation to the injuries suffered. Read more...
Trump's New Health Care Frontier Will reform have investors looking toward telemedicine?
A Donald Trump presidency has many more eyes focused on health care and the adjustment in health care reform that has been frequently discussed by the president. For investors, this tumultuous time could actually be opening up much greater opportunities not only in the health care sector but also the medical technology and telemedicine industries. Read more...
Stocks Steven Cohen Continues to Buy The investor purchased shares of these companies during the last 2 quarters
Steven Cohen (Trades, Portfolio), a billionaire hedge fund investor, is the founder of SAC Capital Advisors, a Stamford, Connecticut-based hedge fund that he continues to manage. He manages a portfolio composed of 668 stocks with a total value of $14.303 billion. In both the fourth and third quarters of 2016 the guru bought shares in the following stocks: Read more...
Investor Confidence in Cigna and Anthem Rises as Health Care Mergers Dealt Blows Both companies gained as dates for decisions pushed back to Trump administration
As a judge struck down a mega merger between health care giants Aetna (NYSE:AET) and Humana (NYSE:HUM) on Tuesday, investor confidence seemed to grow for two other companies seeking to unite in a similar deal, Cigna (NYSE:CI) and Anthem (NYSE:ANTM). Read more...
Dodge & Cox Exits Time Warner Cable, Buys MetLife Guru's largest trades in the 2nd quarter
Dodge & Cox was founded in 1930, by Van Duyn Dodge and E. Morris Cox. During the second quarter the guru’s most heavily weighted trades were as follows: Read more...
52-Week Company Lows Lows of 5 companies
According to the GuruFocus list of 52-week lows, these guru stocks have reached their 52-week lows. Read more...
5 Companies for Defensive Investors Near 52 Week Lows These companies were selected and reviewed by ModernGraham

Ratios

vs
industry
vs
history
PE Ratio 23.23
CI's PE Ratio is ranked lower than
55% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. CI: 23.23 )
Ranked among companies with meaningful PE Ratio only.
CI' s PE Ratio Range Over the Past 10 Years
Min: 3.25  Med: 12.99 Max: 23.24
Current: 23.23
3.25
23.24
Forward PE Ratio 18.08
CI's Forward PE Ratio is ranked lower than
55% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.39 vs. CI: 18.08 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 23.23
CI's PE Ratio without NRI is ranked lower than
52% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.18 vs. CI: 23.23 )
Ranked among companies with meaningful PE Ratio without NRI only.
CI' s PE Ratio without NRI Range Over the Past 10 Years
Min: 3.25  Med: 12.9 Max: 23.24
Current: 23.23
3.25
23.24
Price-to-Owner-Earnings 9.99
CI's Price-to-Owner-Earnings is ranked higher than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.73 vs. CI: 9.99 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CI' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.2  Med: 10.28 Max: 416.97
Current: 9.99
2.2
416.97
PB Ratio 3.14
CI's PB Ratio is ranked lower than
52% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.78 vs. CI: 3.14 )
Ranked among companies with meaningful PB Ratio only.
CI' s PB Ratio Range Over the Past 10 Years
Min: 0.52  Med: 2.22 Max: 3.96
Current: 3.14
0.52
3.96
PS Ratio 1.12
CI's PS Ratio is ranked lower than
67% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.64 vs. CI: 1.12 )
Ranked among companies with meaningful PS Ratio only.
CI' s PS Ratio Range Over the Past 10 Years
Min: 0.13  Med: 0.68 Max: 1.2
Current: 1.12
0.13
1.2
Price-to-Free-Cash-Flow 10.56
CI's Price-to-Free-Cash-Flow is ranked higher than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.35 vs. CI: 10.56 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CI' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 1.8  Med: 12.56 Max: 148
Current: 10.56
1.8
148
Price-to-Operating-Cash-Flow 9.58
CI's Price-to-Operating-Cash-Flow is ranked higher than
55% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.27 vs. CI: 9.58 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CI' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.51  Med: 9.41 Max: 36.49
Current: 9.58
1.51
36.49
EV-to-EBIT 13.61
CI's EV-to-EBIT is ranked higher than
50% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.25 vs. CI: 13.61 )
Ranked among companies with meaningful EV-to-EBIT only.
CI' s EV-to-EBIT Range Over the Past 10 Years
Min: -1.6  Med: 8 Max: 17.8
Current: 13.61
-1.6
17.8
EV-to-EBITDA 11.52
CI's EV-to-EBITDA is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.19 vs. CI: 11.52 )
Ranked among companies with meaningful EV-to-EBITDA only.
CI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1.4  Med: 6.8 Max: 11.7
Current: 11.52
-1.4
11.7
PEG Ratio 1.97
CI's PEG Ratio is ranked higher than
50% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.82 vs. CI: 1.97 )
Ranked among companies with meaningful PEG Ratio only.
CI' s PEG Ratio Range Over the Past 10 Years
Min: 0.27  Med: 0.82 Max: 16.48
Current: 1.97
0.27
16.48
Shiller PE Ratio 30.25
CI's Shiller PE Ratio is ranked lower than
54% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 27.81 vs. CI: 30.25 )
Ranked among companies with meaningful Shiller PE Ratio only.
CI' s Shiller PE Ratio Range Over the Past 10 Years
Min: 3.13  Med: 16.46 Max: 33.95
Current: 30.25
3.13
33.95

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.02
CI's Dividend Yield % is ranked lower than
100% of the 31 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.38 vs. CI: 0.02 )
Ranked among companies with meaningful Dividend Yield % only.
CI' s Dividend Yield % Range Over the Past 10 Years
Min: 0.02  Med: 0.07 Max: 0.57
Current: 0.02
0.02
0.57
Dividend Payout Ratio 0.01
CI's Dividend Payout Ratio is ranked higher than
92% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.25 vs. CI: 0.01 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CI' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.01 Max: 0.04
Current: 0.01
0.01
0.04
Forward Dividend Yield % 0.02
CI's Forward Dividend Yield % is ranked lower than
100% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.65 vs. CI: 0.02 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.02
CI's 5-Year Yield-on-Cost % is ranked lower than
100% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.04 vs. CI: 0.02 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CI' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.02  Med: 0.07 Max: 0.57
Current: 0.02
0.02
0.57
3-Year Average Share Buyback Ratio 2.30
CI's 3-Year Average Share Buyback Ratio is ranked higher than
67% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. CI: 2.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -5.8  Med: 3.2 Max: 11.7
Current: 2.3
-5.8
11.7

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 5.42
CI's Price-to-Tangible-Book is ranked higher than
56% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.27 vs. CI: 5.42 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.72  Med: 3.31 Max: 28
Current: 5.42
0.72
28
Price-to-Intrinsic-Value-Projected-FCF 1.11
CI's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
53% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.04 vs. CI: 1.11 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CI' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.28  Med: 0.77 Max: 1.53
Current: 1.11
0.28
1.53
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.33
CI's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
70% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.60 vs. CI: 1.33 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.65
CI's Price-to-Median-PS-Value is ranked lower than
73% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.23 vs. CI: 1.65 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CI' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.36  Med: 1.03 Max: 3.85
Current: 1.65
0.36
3.85
Price-to-Peter-Lynch-Fair-Value 1.89
CI's Price-to-Peter-Lynch-Fair-Value is ranked lower than
58% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.63 vs. CI: 1.89 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CI' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.35  Med: 0.63 Max: 2.96
Current: 1.89
0.35
2.96
Price-to-Graham-Number 2.37
CI's Price-to-Graham-Number is ranked higher than
92% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.77 vs. CI: 2.37 )
Ranked among companies with meaningful Price-to-Graham-Number only.
CI' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.44  Med: 1.37 Max: 3.75
Current: 2.37
0.44
3.75
Earnings Yield (Greenblatt) % 7.35
CI's Earnings Yield (Greenblatt) % is ranked higher than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.85 vs. CI: 7.35 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CI' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -2750.8  Med: 12 Max: 50506.3
Current: 7.35
-2750.8
50506.3
Forward Rate of Return (Yacktman) % 16.76
CI's Forward Rate of Return (Yacktman) % is ranked higher than
60% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.88 vs. CI: 16.76 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CI' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -2.4  Med: 18.4 Max: 49.4
Current: 16.76
-2.4
49.4

More Statistics

Revenue (TTM) (Mil) $40,169.00
EPS (TTM) $ 7.50
Beta0.48
Short Percentage of Float1.69%
52-Week Range $115.03 - 175.17
Shares Outstanding (Mil)256.01

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 40,950 43,853 47,978
EPS ($) 9.61 11.21 12.80
EPS without NRI ($) 9.61 11.21 12.80
EPS Growth Rate
(Future 3Y To 5Y Estimate)
12.21%
Dividends per Share ($) 0.01 0.01
» More Articles for CI

Headlines

Articles On GuruFocus.com
Cigna and CVS Health Launch Cigna Health Works, A New Model for Customer-Enabled Design for Affordab Jun 08 2017 
Cigna Improves Earnings Despite Policy Uncertainty Over Obamacare Jun 06 2017 
How to Invest in Structured Settlements Apr 14 2017 
A Market of Extremes Mar 14 2017 
Trump's New Health Care Frontier Mar 14 2017 
Stocks Steven Cohen Continues to Buy Mar 02 2017 
Since the Merger With Cigna Seems Doomed, What Are We to Think of Anthem? Feb 22 2017 
Investor Confidence in Cigna and Anthem Rises as Health Care Mergers Dealt Blows Jan 25 2017 
5 Undervalued Companies With a Low Beta Dec 12 2016 
52-Week Company Lows Sep 15 2016 

More From Other Websites
Fresh 52-week Highs on Flaming Hot Stocks - Dave's Daily Dive Jul 20 2017
New Strong Buy Stocks for July 19th Jul 19 2017
Asian shares mostly higher as focus turns to central bankers Jul 18 2017
Trump can’t ‘let’ Obamacare fail — but he can help destroy it Jul 18 2017
UnitedHealth beats profit estimates after Obamacare exit Jul 18 2017
Sen. Mike Lee's Strategy To Preserve Every Word Of Obamacare Jul 18 2017
UnitedHealth Group, AARP Extend Medicare Partnership Beyond 2025 Jul 17 2017
UnitedHealth Faces Moody's Rating Action, Outlook Upgraded Jul 14 2017
[$$] Anthem's New Chapter After Cigna Jul 13 2017
Cigna (CI) Hits 52-Week High on Recent Buyout, Growth Plans Jul 13 2017
Cigna Teams Up with ‘Roll Call Live: Fighting the Opioid Epidemic’ to Host D.C. Forum Addressing... Jul 13 2017
Cigna Global Health Benefits Introduces Market Leading App Jul 12 2017
Cigna Buys Zurich Insurance to Expand in UAE, Shares Gain Jul 12 2017
Horace Mann's (HMN) Q2 Catastrophe Loss May Hit Bottom Line Jul 12 2017
Cigna's Sadler Sees Double Digit Growth in Middle East Jul 12 2017
Sessions to Unveil Health-Care Fraud Crackdown This Week, Sources Say Jul 11 2017
Global Health Services Company Cigna Acquires Zurich Insurance Middle East Jul 11 2017
Marsh & McLennan's (MMC) Unit Launches New Digital Offering Jul 11 2017
MetLife to Buy Logan Circle, Expand Investment Management Jul 10 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}